Eli Lilly and Company (LLY) stock analysis
Arxanth's stance on LLY on three horizons, as of Nov 11, 2026:
- Short term (days): Neutral now. By session: Over the last 27 sessions (Oct 5 – Nov 10): Lean Bullish on 5, Neutral on 22. The last session read Lean Bullish, as every session since Nov 9 (2 sessions); before that, Neutral.
- Medium term (weeks): Neutral now. By session: Over the last 26 sessions (Oct 5 – Nov 9): Neutral on 26. Every session in this window read Neutral.
- Long term (months): Neutral now. By session: Over the last 20 sessions (Oct 5 – Oct 30): Bullish on 2, Neutral on 18. The last session read Neutral, as every session since Oct 9 (16 sessions); before that, Bullish.
What was published each session. Not a measure of performance.
Three agents vote on each horizon and a fourth reads the options map. Where they disagree, the read shows the disagreement rather than resolving it. The Stance history on this page shows how the stance on each horizon moved over the last 7 or 30 sessions, against the price.
Why the stance, its reference levels, the agents' votes, the risk read and the options range are in the Arxanth app for iPhone and iPad, where every plan starts with a 14-day free trial.
SPY's full read is open to everyone: arxanth.com/#/t/SPY.
Other names on Arxanth: QUALCOMM Incorporated (QCOM) · Lockheed Martin Corporation (LMT) · GE Vernova Inc. (GEV) · United Parcel Service, Inc. (UPS) · Alphabet Inc. (GOOGL) · JPMorgan Chase & Co. (JPM) · Bank of America Corporation (BAC) · Chevron Corporation (CVX).
Model-generated analytical output, not a trade recommendation. Arxanth is a decision-support and research tool. It is not a broker or execution venue and cannot place or influence orders. For informational purposes only. Not financial advice. Past performance does not guarantee future results. Arxanth by Arxora, LLC.